Transfected Stable Cell Lines
Reliable | High-Performance | Wide Rage
Precision reporter, kinase, immune receptor, biosimilar, Cas9, and knockout stable cell lines for diverse applications.
Cat. No. : CSC-RT2704
Target Gene : TP53 Host Cell : MV4-11
Size : >1x106 cells/vial Validation : Sequencing
| Cat. No. | CSC-RT2704 |
| Description | This cell is a stable cell line with a homozygous knockout of human TP53 using CRISPR/Cas9. |
| Target Gene | TP53 |
| Host Cell | MV4-11 |
| Host Cell Species | Homo sapiens (Human) |
| Size | 1 vial (10^6 cell/vial) |
| Validation | Sequencing |
| Storage | Liquid nirtogen |
| Shipping | Dry ice package |
| Revival | Rapidly thaw cells in a 37°C water bath. Transfer contents into a tube containing pre-warmed media. Centrifuge cells and seed into a 25 cm2 flask containing pre-warmed media. |
| Mycoplasma | Negative |
| Format | One frozen vial containing millions of cells |
| Storage | Liquid nitrogen |
| Safety Considerations |
The following safety precautions should be observed. 1. Use pipette aids to prevent ingestion and keep aerosols down to a minimum. 2. No eating, drinking or smoking while handling the stable line. 3. Wash hands after handling the stable line and before leaving the lab. 4. Decontaminate work surface with disinfectant or 70% ethanol before and after working with stable cells. 5. All waste should be considered hazardous. 6. Dispose of all liquid waste after each experiment and treat with bleach. |
| Ship | Dry ice |
| Target Gene | TP53 |
| Background | This gene encodes a tumor suppressor protein containing transcriptional activation, DNA binding, and oligomerization domains. The encoded protein responds to diverse cellular stresses to regulate expression of target genes, thereby inducing cell cycle arrest, apoptosis, senescence, DNA repair, or changes in metabolism. Mutations in this gene are associated with a variety of human cancers, including hereditary cancers such as Li-Fraumeni syndrome. Alternative splicing of this gene and the use of alternate promoters result in multiple transcript variants and isoforms. Additional isoforms have also been shown to result from the use of alternate translation initiation codons from identical transcript variants (PMIDs: 12032546, 20937277). [provided by RefSeq, Dec 2016] |
The TP53 gene, also known as "tumor protein p53", is one of the most intensively studied and important genes in cancer research because of its key role in maintaining genome stability and acting as a tumor suppressor. The TP53 gene is located on the short arm of chromosome 17 (17p13.1) and spans approximately 20 kilobases, including several highly conserved regions. The protein product, p53, functions primarily by binding to DNA and regulating the expression of target genes. This regulation is essential for initiating DNA repair processes when damage occurs, halting the cell cycle to provide time for repair, and triggering apoptosis when necessary to prevent the proliferation of cells with DNA errors.
TP53 gene mutations are the most common genetic alterations in human cancer, present in more than 50% of cases. These mutations often result in the loss of functional p53 protein, leading to uncontrolled cell division and tumor development. The gene can be affected by point mutations, insertions, deletions, and other variations that affect coding sequences and regulatory regions. The therapeutic potential of targeting the p53 pathway in cancer treatment is enormous. Strategies include restoring wild-type p53 function in mutant cancers or reactivating p53 in the presence of oncogenic inhibitors. In addition, the role of p53 in cellular stress responses extends its relevance beyond oncology to areas such as aging and the treatment of other diseases involving genomic instability.
The TP53 gene encodes the tumor protein p53, which plays a key role in regulating the cell cycle and preventing cancer formation. TP53 knockout cell lines, such as the MV-4-11 cell line, are valuable tools in a variety of research areas. Here are some key applications:
Cancer Research: The TP53 knockout MV-4-11 cell line is essential for studying the role of the TP53 gene in cancer development. The TP53 gene is known as the "guardian of the genome" for its role in preventing genomic mutations. Studies involving TP53 knockout cells help understand how mutations in this gene lead to cancer progression.
Drug Screening and Development: By comparing the effects of drugs on TP53 knockout cells and wild-type cells, researchers can identify compounds that specifically target pathways affected by loss of TP53 function.
Gene Function Studies: TP53 knockout cell lines allow scientists to study the specific functions of the TP53 gene in cell cycle regulation, apoptosis, and DNA repair mechanisms.
Tumor Suppression Mechanism Studies: Researchers can use these cell lines to elucidate the molecular mechanisms by which TP53 suppresses tumor formation. This can reveal potential therapeutic targets in TP53-regulated pathways.
Pathway Analysis: Utilizing TP53 knockout cell lines facilitates the analysis of cellular pathways that are altered due to TP53 loss. This can include pathways involved in cell proliferation, senescence, and response to DNA damage, providing a comprehensive understanding of the role of TP53 in maintaining cellular homeostasis.
A: The knockout cell product is validated by PCR amplification and Sanger Sequencing to confirm the mutation at the genomic level. Please find the detailed mutation info in the datasheet.
A: Single clonal cell.
A: No. This knockout cell product is generated using the CRISPR/Cas9 system to induce small insertions or deletions (indels) resulting in frameshift mutations. Although these frameshift mutations typically disrupt the coding gene, there is a possibility that the non-functional transcript may still be transcribed. Consequently, this could potentially yield misleading results when analyzed by RT-qPCR.
A: The cell line should be stored in liquid nitrogen for long-term preservation.
A: For most cases, we often keep at least 2 clones with different frameshift mutations. Please feel free to contact us to check if there are additional available clones.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
I've been using the Human TP53 Knockout Cell Line MV-4-11 for my oncology research, and it has provided reliable and consistent results every time.
This TP53 knockout cell line has been instrumental in our functional assays. The knockout efficiency is excellent, and it allows us to investigate gene function and drug responses in a more precise manner.
Write a review of your use of Biogene products and services in your research. Your review can help your fellow researchers make informed purchasing decisions.